A multicenter randomized phase III study of albumin-bound paclitaxel combined with S-1 (AS) versus oxaliplatin combined with S-1 (SOX) for first-line treatment of advanced gastric cancer (GAPSO study)

Category Primary study
JournalJOURNAL OF CLINICAL ONCOLOGY
Year 2022
This article has no abstract
Epistemonikos ID: 199d7abf25d84d2b47250cf9a8f7c4322e44a9fb
First added on: Feb 13, 2025